Wu H - Search Results

1

Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes.

Chen S, Zhou M, Wang W, Wu H, Yu X, Huang W, Gao X, Wang J, Li X, Du S, Ding X, Zhang X. Chen S, et al. Among authors: wu h. Acta Ophthalmol. 2015 Nov;93(7):e556-60. doi: 10.1111/aos.12624. Epub 2015 Mar 17. Acta Ophthalmol. 2015. PMID: 25783445 Free article.

2

Self-Assembling RADA16-I Peptide Hydrogel Scaffold Loaded with Tamoxifen for Breast Reconstruction.

Wu H, Zhou T, Tian L, Xia Z, Xu F. Wu H, et al. Biomed Res Int. 2017;2017:3656193. doi: 10.1155/2017/3656193. Epub 2017 Jun 12. Biomed Res Int. 2017. PMID: 28691024 Free PMC article.

3

Impact of a pharmacist-led education and follow-up service on anticoagulation control and safety outcomes at a tertiary hospital in China: a randomised controlled trial.

Liang JB, Lao CK, Tian L, Yang YY, Wu HM, Tong HH, Chan A. Liang JB, et al. Int J Pharm Pract. 2020 Feb;28(1):97-106. doi: 10.1111/ijpp.12584. Epub 2019 Oct 1. Int J Pharm Pract. 2020. PMID: 31576625 Clinical Trial.

4

Impact of Clinical Pharmacy Services on KAP and QOL in Cancer Patients: A Single-Center Experience.

Wang Y, Wu H, Xu F. Wang Y, et al. Among authors: wu h. Biomed Res Int. 2015;2015:502431. doi: 10.1155/2015/502431. Epub 2015 Nov 30. Biomed Res Int. 2015. PMID: 26697487 Free PMC article. Clinical Trial.

5

FAP-targeted radioligand therapy with ⁶⁸Ga/¹⁷⁷Lu-DOTA-2P(FAPI)₂ enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy.

Chen J, Zhou Y, Pang Y, Fu K, Luo Q, Sun L, Wu H, Lin Q, Su G, Chen X, Zhao L, Chen H. Chen J, et al. Among authors: wu h. J Immunother Cancer. 2025 Jan 11;13(1):e010212. doi: 10.1136/jitc-2024-010212. J Immunother Cancer. 2025. PMID: 39800373

6

LncRNA-AC006129.1 Aggravates kidney hypoxia-ischemia injury by promoting CXCL2-dependent inflammatory response.

Chen RY, Xie H, Zhuang SY, Liu XW, Wu HY, Yuan XD, Zhang M, Zhong C, Li DW. Chen RY, et al. Among authors: wu hy. Int Immunopharmacol. 2025 Jan 11;147:113920. doi: 10.1016/j.intimp.2024.113920. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39799734

7

From natural herbal wisdom to nano innovation: Revolutionizing tumor treatment through metabolic reprogramming.

Zhang Z, Wu H, Li M, Zhou F, Huang Y. Zhang Z, et al. Among authors: wu h. Biochim Biophys Acta Rev Cancer. 2025 Jan 10:189263. doi: 10.1016/j.bbcan.2025.189263. Online ahead of print. Biochim Biophys Acta Rev Cancer. 2025. PMID: 39800231 Review.

8

Chemical corrosion resistance mechanism of titanium alloy radiation rods with self-protected structure.

Cao H, Dong F, Zhang Q, Wu H. Cao H, et al. Among authors: wu h. Ultrason Sonochem. 2025 Jan 7;113:107224. doi: 10.1016/j.ultsonch.2025.107224. Online ahead of print. Ultrason Sonochem. 2025. PMID: 39799861

9

Ergosterol alleviates hepatic steatosis and insulin resistance via promoting fatty acid β-oxidation by activating mitochondrial ACSL1.

Zheng ZG, Zhang YP, Zhang XY, Qin MY, Xu YY, Wu H, Liu RQ, Wu QY, Wang MS, Zhang C, Zheng YQ, Dai JY, Li P, Yang H. Zheng ZG, et al. Among authors: wu h. Cell Rep. 2025 Jan 10;44(1):115203. doi: 10.1016/j.celrep.2024.115203. Online ahead of print. Cell Rep. 2025. PMID: 39799570

10

Corrigendum to "The SP1/SIRT1/ACLY signaling axis mediates fatty acid oxidation in renal ischemia-reperfusion-induced renal fibrosis" [Int. Immunopharmacol. 132 (2024) 112002].

Wu H, Wang L, Kang P, Zhou X, Li W, Xia Z. Wu H, et al. Int Immunopharmacol. 2025 Jan 10:113963. doi: 10.1016/j.intimp.2024.113963. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39799025 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,398 results

Search Page

Filters